| Package | dk.kip.rkkp.fhir.ig.core |
| Resource Type | ValueSet |
| Id | BehandlingCML |
| FHIR Version | R4 |
| Source | https://kip.rkkp.dk/fhir/https://build.fhir.org/ig/KIP-infrastructure/implementation-guide/ValueSet-BehandlingCML.html |
| URL | https://kip.rkkp.dk/fhir/ValueSet/BehandlingCML |
| Version | 2.12.0 |
| Status | active |
| Date | 2022-07-18T00:00:00+02:00 |
| Name | BehandlingCML |
| Title | Behandling (CML) |
| Description | Behandling (CML) |
No resources found
| CodeSystem | |
| ATC | WHO ATC |
| ATCMixedCodes | WHO ATC; Mixed codes |
| GenericValues | Generic values |
Note: links and images are rebased to the (stated) source
Generated Narrative: ValueSet BehandlingCML
This value set includes codes based on the following rules:
FHIRhttps://kip.rkkp.dk/fhir/CodeSystem/ATC| Code | Display | Definition |
| L01EA06 | Asciminib | L01EA06 - Asciminib |
| L01XX05 | Hydroxycarbamide | L01XX05 - hydroxycarbamide |
| L01EA01 | Imatinib | L01EA01 - imatinib |
| L01EA02 | Dasatinib | L01EA02 - dasatinib |
| L01EA03 | Nilotinib | L01EA03 - nilotinib |
| L03AB | Interferon | L03AB - Interferons |
| L01EA04 | Bosutinib | L01EA04 - bosutinib |
| L01EA05 | Ponatinib | L01EA05 - ponatinib |
https://kip.rkkp.dk/fhir/CodeSystem/ATCMixedCodes| Code | Display | Definition |
| tki | Anden TKI behandling | TKI (Tyrosine kinase inhibitors) |
https://kip.rkkp.dk/fhir/CodeSystem/GenericValues| Code | Display | Definition |
| other | Anden behandling | Other - used to choose unspecific value not in a valueset |
{
"resourceType": "ValueSet",
"id": "BehandlingCML",
"text": {
"status": "extensions",
"div": "<!-- snip (see above) -->"
},
"url": "https://kip.rkkp.dk/fhir/ValueSet/BehandlingCML",
"version": "2.12.0",
"name": "BehandlingCML",
"title": "Behandling (CML)",
"status": "active",
"experimental": true,
"date": "2022-07-18T00:00:00+02:00",
"publisher": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
"contact": [
{
"name": "Sundhedsvæsenets Kvalitetsinstitut with Trifork Digital Health A/S",
"telecom": [
{
"system": "url",
"value": "https://trifork.com"
},
{
"system": "email",
"value": "rbk@trifork.com"
}
]
}
],
"description": "Behandling (CML)",
"compose": {
"include": [
{
"system": "https://kip.rkkp.dk/fhir/CodeSystem/ATC",
"concept": [
{
"code": "L01EA06",
"display": "Asciminib"
},
{
"code": "L01XX05",
"display": "Hydroxycarbamide"
},
{
"code": "L01EA01",
"display": "Imatinib"
},
{
"code": "L01EA02",
"display": "Dasatinib"
},
{
"code": "L01EA03",
"display": "Nilotinib"
},
{
"code": "L03AB",
"display": "Interferon"
},
{
"code": "L01EA04",
"display": "Bosutinib"
},
{
"code": "L01EA05",
"display": "Ponatinib"
}
]
},
{
"system": "https://kip.rkkp.dk/fhir/CodeSystem/ATCMixedCodes",
"concept": [
{
"code": "tki",
"display": "Anden TKI behandling"
}
]
},
{
"system": "https://kip.rkkp.dk/fhir/CodeSystem/GenericValues",
"concept": [
{
"code": "other",
"display": "Anden behandling"
}
]
}
]
}
}